Drug Trial Radar · NCT07251595
A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo
Last checked: Nov 19, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
176
Planned (sponsor's estimate)
Start
Dec 5, 2025
Primary completion
Mar 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.
Conditions
- Non-segmental Vitiligo
Interventions
SHR0302 TabletsDrug
SHR0302 tablets.
SHR0302 Base GelDrug
SHR0302 Base gel.
SHR0302 Placebo TabletsDrug
SHR0302 placebo tablets.
SHR0302 Base Placebo GelDrug
SHR0302 Base placebo gel.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The percentage change in the facial vitiligo area score index (F-VASI) from the baseline.Time frame: At Week 24.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dermatology Hospital affiliated to Shandong First Medical University
Jinan, Shandong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.